<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03885583</url>
  </required_header>
  <id_info>
    <org_study_id>aunanesth202019</org_study_id>
    <nct_id>NCT03885583</nct_id>
  </id_info>
  <brief_title>Post-operative Pulmonary Function After Thoracotomy Under Two Different Techniques</brief_title>
  <official_title>Evaluation of Post-operative Pulmonary Function After Open Thoracotomy: Comparison Between Thoracic Epidural and Paravertebral Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the respiratory and analgesic effects of continuous thoracic paravertebral block&#xD;
      versus thoracic epidural in patients undergoing thoracotomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study tools&#xD;
&#xD;
        -  An Ultrasound machine (Madison X6) with superficial linear and curved probe.&#xD;
&#xD;
        -  A 19 gauge echogenic needle and Plexolong Cather (PAJUNK, Plexolong Meier nanoline,&#xD;
           Geisingen, Germany; 60 mm).&#xD;
&#xD;
        -  A 17-gauge Tuohy needle and 19 G flex-tip catheter: for thoracic epidural.&#xD;
&#xD;
        -  Spirometer: (Enraf-Nonius, Model SPIRO 601).&#xD;
&#xD;
        -  Drugs: isobaric bupivacaine 0.25% (aside from the drugs used in the standard operation&#xD;
           theatre).&#xD;
&#xD;
        -  Computer software: computer generated random tables (for randomization) and SPSS 22 (for&#xD;
           data analysis)&#xD;
&#xD;
      Thoracic epidural (TEP):&#xD;
&#xD;
      A pre-procedural ultrasound examination will be done to first identify the correct targeted&#xD;
      thoracic level. To accomplish this, the transducer will be placed in the parasagittal plane&#xD;
      approximately 5 cm from midline. The thoracic level will be determined by identifying the&#xD;
      12th rib and counting in a cephalad direction until the targeted level is marked.&#xD;
&#xD;
      All epidurals will be performed under all aseptic precautions with a 17-gauge Tuohy needle&#xD;
      and 19 G flex-tip catheters. Using the loss of resistance to saline technique, catheters will&#xD;
      be inserted 4 cm into the epidural space and a suitable test dose will be administered to&#xD;
      exclude intravascular or sub-arachnoid injection&#xD;
&#xD;
      Bupivacaine 0.25% of 7.5-12 ml volume will be given through the epidural catheter then&#xD;
      continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h&#xD;
      with bolus infusion of 5 to 10 ml of the infusion mixture for breakthrough pain. The block&#xD;
      height will be tested using pin prick method. After spirometry testing and diaphragmatic&#xD;
      ultrasound, the infusion of TEP will be gradually weaned of and the catheter will be removed&#xD;
      under complete aseptic precautions.&#xD;
&#xD;
      Thoracic paravertebral block: (TPVB) The Ultrasound-probe will be centered on T7. The&#xD;
      sagittal technique at the transverse process, in-plane, will be used. The 19 gauge echogenic&#xD;
      needle will be inserted in-plane at the lower border of the transducer and advanced in a&#xD;
      cephalad position with real-time ultrasound sonography.&#xD;
&#xD;
      Injection of small amounts of fluid (hydro-dissection) will aid in needle tip location. When&#xD;
      the needle tip reaches the paravertebral space, 7.5-12 ml Bupivacaine 0.25% will be slowly&#xD;
      injected after negative aspiration. The endpoint for a successful block is anterior&#xD;
      displacement of the pleura. The catheter will be then inserted through the needle and&#xD;
      positioned up to 3 cm from skin entry directing upwards in the paravertebral space then&#xD;
      continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h&#xD;
      with bolus infusion of 5 to 10 ml of the infusion mixture for breakthrough pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">May 1, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vital capacity</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>forced vital capacity</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>forced expiratory volume in one second</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Tecnologies)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>pain will be assessed using VAS score, it provides a range of scores from 0-100. A higher score indicates greater pain intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diaphragmatic excursion</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>ultrasound assessment of diaphragmatic excursion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pulmonary Function</condition>
  <arm_group>
    <arm_group_label>thoracic epidural group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this group will receive ultrasound guided thoracic epidural block preoperatively for pain management, continuous infusion of 0.5% bupivacaine through epidural catheter during operation and early post-operative period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paravertebral group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this group will receive ultrasound guided pararvertebral block preoperatively for pain management, continuous infusion of paravertebral bupivacaine 0.5% through paravetebral catheter during operation and early post-operative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>thoracic epidural block</intervention_name>
    <description>thoracic epidural block with bupivacaine 0.25% will be given in the 8th thoracic space using ultrasound</description>
    <arm_group_label>thoracic epidural group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>paravertebral block</intervention_name>
    <description>paravertebral block with 0.25 bupivacaine will be given at the level of the incision using ultrasound</description>
    <arm_group_label>paravertebral group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA II, III&#xD;
&#xD;
          -  elective thoracotomy surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient refusal&#xD;
&#xD;
          -  contraindications to neuraxial blocks&#xD;
&#xD;
          -  pneumonectomy&#xD;
&#xD;
          -  planed postoperative mechanical ventilatoin&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed G Abdelraheem, MD</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khaled A Abdelrahman, MD</last_name>
    <phone>00200882413201</phone>
    <email>khbaqy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Hamdy A Youssef, MD</last_name>
      <phone>00208824132.4</phone>
      <email>hamdyayoussef@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>March 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2019</study_first_posted>
  <last_update_submitted>March 21, 2019</last_update_submitted>
  <last_update_submitted_qc>March 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Khaled Abdelbaky Abdelrahman</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>thoracotomy</keyword>
  <keyword>thoracic epidural block</keyword>
  <keyword>paravertebral block</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

